Manorama Industries Posts Stellar 73% Revenue Jump, Plans ₹460 Cr Expansion

CHEMICALS
Whalesbook Logo
AuthorKavya Nair|Published at:
Manorama Industries Posts Stellar 73% Revenue Jump, Plans ₹460 Cr Expansion
Overview

Manorama Industries reported robust Q3 FY26 results, with standalone revenue soaring 73.2% YoY to ₹36.25 Cr and PAT jumping 131.2% YoY to ₹6.83 Cr. The company also announced a significant capital expenditure plan of approximately ₹460 crores over the next two to three years to enhance manufacturing capacity for Cocoa Butter Alternative and other facilities, signalling strong future growth prospects.

📉 The Financial Deep Dive

Manorama Industries Limited has delivered an exceptional performance for the third quarter of FY26, showcasing robust year-on-year growth across key financial metrics. Standalone revenue from operations surged by 73.2% to ₹36.25 crore in Q3 FY26, up from ₹20.92 crore in the corresponding quarter of FY25. This impressive top-line growth was complemented by an even stronger bottom-line expansion, with standalone Profit After Tax (PAT) leaping 131.2% to ₹6.83 crore, compared to ₹2.95 crore in Q3 FY25. Consequently, standalone basic Earnings Per Share (EPS) saw a substantial improvement, rising to ₹11.43 from ₹4.35 YoY.

Consolidated figures mirrored this positive trend, with revenue also growing by 73.2% YoY to ₹36.25 crore, and consolidated PAT escalating by 137.2% YoY to ₹7.23 crore. For the nine months ended December 31, 2025, the company reported standalone revenue of ₹992.08 crore and PAT of ₹173.70 crore, indicating sustained operational strength.

🚀 Strategic Analysis & Impact

Beyond the stellar quarterly results, Manorama Industries has laid out an ambitious growth blueprint. The Board of Directors has greenlit a substantial capital expenditure (Capex) plan of approximately ₹460 crore, to be executed over the next two to three years. This significant investment is earmarked for crucial capacity enhancements, including the establishment of new facilities for Cocoa Butter Alternative (CBA) with a substantial input capacity of 75,000 MTPA, a Solvent Fractionation facility (75,000 MTPA), and a Refinery facility (90,000 MTPA).

Furthermore, the Capex plan extends to backward integration through a processing factory in Burkina Faso, aiming to secure raw material supply and optimize the value chain. These investments underscore the company's strategic intent to bolster its manufacturing prowess, expand its product portfolio, and consolidate its market position in the exotic seed-based fats and butters segment.

🚩 Risks & Outlook

While the growth trajectory and expansion plans are highly promising, investors will monitor the execution of this ₹460 crore Capex. The company's ability to successfully commission new facilities, integrate backward operations in Burkina Faso, and manage potential cost overruns will be critical. The market demand for CBA and other specialized fats will also play a key role. Funding for this Capex is planned through internal accruals, debt, or equity, the specific mix of which will influence the company's leverage and profitability metrics. Management's view on the impact of new labour codes being 'not material' suggests limited near-term regulatory headwinds.

The forward view is strongly positive, driven by enhanced capacity and strategic backward integration, positioning Manorama Industries for sustained long-term growth in its niche segment.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.